.
the patient was treated at the royal devon & exeter nhs foundation trust..
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports..
.